Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/97407
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review
Author: Hocking, C.
Kichenadasse, G.
Citation: Supportive Care in Cancer, 2014; 22(4):1143-1151
Publisher: Springer
Issue Date: 2014
ISSN: 0941-4355
1433-7339
Statement of
Responsibility: 
Christopher M. Hocking, Ganessan Kichenadasse
Abstract: Purpose: Newer drugs incorporated in prophylactic regimens for chemotherapy-induced nausea and vomiting (CINV) have resulted in significantly reduced rates of this feared complication of cytotoxic chemotherapy. However, both delayed chemotherapy-induced nausea and breakthrough CINV remain difficult areas of management and require novel treatment strategies. Recent randomized trial evidence has suggested that olanzapine, an atypical antipsychotic, may have a role in both the prevention and treatment of CINV. A systematic review was conducted to assess the efficacy of olanzapine in (a) preventing CINV in highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC) and (b) the treatment of breakthrough CINV. The toxicity of olanzapine in this setting was also reviewed. Methods: MEDLINE, Embase and Cochrane Database of Systematic Reviews databases were searched to identify all randomized clinical trials (RCTs) investigating olanzapine in patients receiving chemotherapy. Results: A total of 488 patients from three trials of CINV prophylaxis and 323 patients from three trials of breakthrough CINV were included. Regimens including olanzapine were associated with significant improvements in CINV prevention with both HEC and MEC. Single agent olanzapine for breakthrough nausea was superior to standard alternative options. Conclusion: Data from RCTs support the use of an olanzapine containing combination regimen as an option for CINV prophylaxis and single agent olanzapine for the treatment of breakthrough CINV. In the included trials, the short duration of olanzapine appears safe and well tolerated.
Keywords: Olanzapine
Chemotherapy-induced nausea and vomiting
Supportive care
Clinical trials
Rights: © Springer-Verlag Berlin Heidelberg 2014
DOI: 10.1007/s00520-014-2138-y
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.